FFR-Guided PCI · 5 Year Cardiac Death / MI in DEFER study5 Year Cardiac Death / MI in DEFER study...
Transcript of FFR-Guided PCI · 5 Year Cardiac Death / MI in DEFER study5 Year Cardiac Death / MI in DEFER study...
Stanford
FFR-Guided PCIFFR-Guided PCI
William F. Fearon, M.D.Associate Professor
Division of Cardiovascular MedicineStanford University Medical Center
4th Imaging and Physiology SummitOctober 29th, 2010Seoul, Korea
Stanford
Disclosure Statement of Financial InterestDisclosure Statement of Financial Interest
I, William Fearon, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
Stanford receives research support from St. Jude Medical.
Stanford
Why do we need FFR?Why do we need FFR?
• Importance of ischemia
• Limitations of noninvasive testing
• Limitations of angiography
• Limitations of IVUS/OCT
Stanford
Importance of IschemiaImportance of Ischemia
0.30.8
2.3
4.6
0
0.9 1.1 1.3
0
1
2
3
4
5
Nl Mild Abnl Mod Abnl Sev Abnl
Nuclear Scan Result
Car
diac
Dea
th (%
/yr)
Medical Therapy Revascularization
Hachamovitch et al. Circulation 1998;97:535-543
Nuclear perfusion scans performed in > 5000 patients
Stanford
COURAGE Nuclear SubstudyCOURAGE Nuclear Substudy
Shaw et al. Circulation 2008;117:1283
Comparison of death/MI in patients with mod-severe pre-treatment ischemia
StanfordJAMA 2008;300:1765
Stanford
FFR vs. Nuclear Perfusion Scan in MVDFFR vs. Nuclear Perfusion Scan in MVD
Melikian et al. J Am Coll Cardiol Int 2010;3:307-14
67 patients with angiographic 2 or 3 vessel CAD
Stanford
FFR vs. Nuclear Perfusion Scan in MVDFFR vs. Nuclear Perfusion Scan in MVD
Melikian et al. J Am Coll Cardiol Int 2010;3:307-14
67 patients with angiographic 2 or 3 vessel CAD
Stanford
Limitation of AngiographyLimitation of Angiography
0 10 20 30 40 50 60 70 80 90 1000.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Diameter Stenosis (%)
FFR
Courtesy of Bernard De Bruyne, MD, PhD
Comparison of QCA to FFR in over 3,000 lesions
(-) Ischemia
(+) Ischemia
Stanford
FFR should not guide ALL PCI!FFR should not guide ALL PCI!70 year old man with angina and anterior ischemia
Stanford
When should we use FFR?When should we use FFR?
• In patients with coronary narrowings in the 50-90% range and unclear, equivocal or absent noninvasive stress imaging studies.
– Most commonly in patients with multivessel CAD.
Stanford
Which Lesions Need FFR?Which Lesions Need FFR?1329 lesions in the FFR-guided arm of the FAME Study
~35%
~20%
J Am Coll Cardiol 2010;55:2816-21.
Stanford
Why should FFR Guide PCI?Why should FFR Guide PCI?
• Improves outcomes• Saves money• PCI of intermediate lesions is not benign• Medical treatment of hemodynamically
insignificant lesions is safe• FFR-guided PCI can simplify a procedure
and may increase PCI volume
Stanford
Why should FFR Guide PCI?Why should FFR Guide PCI?
• Improves outcomes• Saves money• PCI of intermediate lesions is not benign• Medical treatment of hemodynamically
insignificant lesions is safe• FFR-guided PCI can simplify a procedure
and may increase PCI volume
StanfordNew Engl J Med 2009;360:213-24.
FAME Study: One Year OutcomesFAME Study: One Year Outcomes
3
8.7 9.511.1
18.3
1.8
5.7 6.5 7.3
13.2
0
5
10
15
20
Death MI RepeatRevasc
Death/MI MACE
Angio-Guided FFR-Guided
p=0.02p=0.04
%
~40%
~35% ~30% ~35%
~30%
Over 1,000 patients with MVD undergoing PCI and randomized to FFR or angiographic guidance alone
Stanford
FAME Study: Two Year OutcomesFAME Study: Two Year Outcomes
FFRFFR--GuidedGuided
AngioAngio--GuidedGuided
730 days730 days4.5%4.5%
J Am Coll Cardiol 2010;56:177-184
Stanford
FAME: 1 Year Economic EvaluationFAME: 1 Year Economic Evaluation
USD
Bootstrap SimulationBootstrap Simulation
Fearon, et al. Circulation 2010; (in press)-5000
-4000
-3000
-2000
-1000
0
1000
2000
3000
4000
-0.050 -0.025 0.000 0.025 0.050 0.075 0.1
Increm. QALY
Incr
em. C
ost [
$]
FFR Guidance Improves outcomes
FFR Guidance Saves Resources
ICER of 50,000 $ / QALY1 Year CostsAngio ~ $16,700 / patientFFR ~ $14,300 / patient
FFR BetterAngio Better
Angio Less
Costly
FFR Less
Costly
Stanford
Why should FFR Guide PCI?Why should FFR Guide PCI?
• Improves outcomes• Saves money• PCI of intermediate lesions is not benign• Medical treatment of hemodynamically
insignificant lesions is safe• FFR-guided PCI can simplify a procedure
and may increase PCI volume
Stanford
Should we perform PCI in all intermediate lesions?
Should we perform PCI in all intermediate lesions?
Moses JW, et al. J Am Coll Cardiol 2006;47:2164-71.
92 lesions with QCA < 50% stenosis treated with DES
Stanford
What is the Expected MACE in DES-Treated Intermediate Lesions?
What is the Expected MACE in DES-Treated Intermediate Lesions?
Moses JW, et al. J Am Coll Cardiol 2006;47:2164-71.
1 year events in 92 intermediate lesions treated with DES
1 Year Cardiac Death and MI rate of 3.4%
Stanford
5 Year Cardiac Death / MI in DEFER study5 Year Cardiac Death / MI in DEFER study
Pijls et al. J Am Coll Cardiol 2007;49:2105-11
3.3
7.9
15.7
0
5
10
15
20 %
P=0.20
P< 0.003
P< 0.005
DEFER PERFORM REFERENCEFFR ≥ 0.75 FFR < 0.75
181 patients with intermediate lesions and FFR ≥0.75 randomized to PCI or deferral
Stanford
2 Year Outcome of Deferred Lesions in FAME2 Year Outcome of Deferred Lesions in FAME
513 Deferred Lesions in513 Deferred Lesions in509 FFR509 FFR--Guided PatientsGuided Patients
2 Years2 Years
31 31 Myocardial InfarctionsMyocardial Infarctions 2222PeriPeri--proceduralprocedural
99Late Myocardial InfarctionsLate Myocardial Infarctions
88Due to a New Lesion Due to a New Lesion
or Stentor Stent--RelatedRelated
11Myocardial Infarction due toMyocardial Infarction due to
an Originally Deferred Lesionan Originally Deferred Lesion
Only 1/513 or 0.2% of deferred Only 1/513 or 0.2% of deferred lesions resulted in a late lesions resulted in a late
myocardial infarctionmyocardial infarction
Stanford
Why should FFR Guide PCI?Why should FFR Guide PCI?
• Improves outcomes• Saves money• PCI of intermediate lesions is not benign• Medical treatment of hemodynamically
insignificant lesions is safe• FFR-guided PCI can simplify a procedure
and may increase PCI volume
Stanford
Recent Case: “Mr. H.”Recent Case: “Mr. H.”
• 79 year old retired physicist with angina• Risk factors include HTN and dyslipidemia• Stress echo revealed anteroseptal and
apical ischemia• Referred for coronary angiography on
September 10th, 2010…
Stanford
Stanford
Stanford
Stanford
Stanford
How should we handle this case?How should we handle this case?
Wijns W, Kolh P, et al. Eur Heart J 2010; in press
Recently published European guidelines for revascularizationRecently published European guidelines for revascularization
Calculated Calculated SYNTAX SYNTAX score = 25.5score = 25.5
Stanford
PCI vs. CABG Outcomes Based on Syntax ScorePCI vs. CABG Outcomes Based on Syntax Score
Serruys et al. N Engl J Med 2009;360:961-72
Worse outcomes with PCI vs CABG with higher SYNTAX scoreWorse outcomes with PCI vs CABG with higher SYNTAX score
>22
≥33
Stanford
PCI vs. CABG Outcomes Based on Syntax ScorePCI vs. CABG Outcomes Based on Syntax Score
Serruys et al. N Engl J Med 2009;360:961-72
Similar outcomes with PCI vs CABG with lower SYNTAX scoreSimilar outcomes with PCI vs CABG with lower SYNTAX score
0-22
Stanford
FFR of RCA = 0.91
Stanford
How should we handle this case?How should we handle this case?
Wijns W, Kolh P, et al. Eur Heart J 2010; in press
Recently published European guidelines for revascularizationRecently published European guidelines for revascularization
Recalculated Recalculated SYNTAX SYNTAX score after score after FFR = 18.5FFR = 18.5
Stanford
Stanford
e-mail from Mr. H.e-mail from Mr. H.
Sept. 19th, 2010:
Dr. Fearon....this is from New Mexico. Yesterday we were walking around on the base of the Santa Fe ski area at over 10,300 feet. Not too strenuous but then not too much air there. Feeling great and just wanted to tell you and say thanks...Bill
Stanford
3VD (14%)0VD (9%)
1VD (34%) 2VD (43%)
Angiographic3 VesselDisease
Anatomic vs. Functional CADAnatomic vs. Functional CAD
Tonino et al., JACC 2010;55:2816-21
Stanford
Change in SYNTAX score after FFRChange in SYNTAX score after FFR
166(34%)
170(35%)
160(32%)
CW Nam, MD (preliminary data)
Without FFR
SYNTAX score in roughly 500 FAME patients before and after FFR
281(57%)
119(24%)
95(19%)
With FFR
Lowest Tertile
Middle Tertile
Highest Tertile
Stanford
Impact of FFR on SYNTAX ScoreImpact of FFR on SYNTAX ScorePrognostic value of SYNTAX score improves after incorporating FFR
N=281 N=119 N=95N=166 N=170 N=160
P<0.001
CW Nam, MD (preliminary data)
Stanford
2009 U.S. PCI Guidelines Update2009 U.S. PCI Guidelines Update
1. FFR can be useful to determine if PCI is warranted, particularlyif the noninvasive test is absent or equivocal. It is reasonableto use FFR for assessing the need for PCI of intermediate lesions (IIa)
2. FFR is not warranted to assess an angiographically significant stenosis if there is angina present and an unequivocally positive stress test in a concordant vascular distribution (III)
Circulation 2009;120:2271-2306
Stanford
2010 European PCI Guidelines2010 European PCI Guidelines
Wijns W, Kolh P, et al. Eur Heart J 2010; in press
FFR Receives IA Recommendation
Stanford
Should FFR Guide PCI?Should FFR Guide PCI?
• Yes, in most cases, FFR will:– Simplify your procedure– Save money– And most importantly, improve your patient’s
outcome!